Kalvista Pharmaceuticals Inc (KALV)
SG&A Expense Growth
26.00%
Quarterly · Period ending:
KALV SG&A Expense Growth
Latest reported26.00%period ending
Latest reported26.00%period ending
KALV Quarterly SG&A Growth (QoQ) (0.00% → 26.00%)
Latest values, visible window
High-resolution chart · PNG
KALV sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 25.9991% | |
| -17.3534% | |
| 4.1045% | |
| 14.1649% | |
| 28.9758% | |
| 3.9211% | |
| 65.9053% | |
| -24.1565% | |
| 122.6946% | |
| -2.2145% | |
| 8.9005% | |
| 25.8326% | |
| 13.0049% | |
| -11.837% | |
| -3.9852% | |
| 7.0018% | |
| 9.4024% | |
| 14.6607% | |
| 3.5916% | |
| -5.1582% | |
| 73.1742% | |
| -2.0094% | |
| 10.8298% | |
| -0.5461% | |
| 7.4316% | |
| -10.2924% | |
| 5.328% | |
| 6.5638% | |
| 5.069% | |
| 11.1537% | |
| 10.038% | |
| 21.1548% | |
| -8.0789% | |
| -21.2357% | |
| 30.3907% | |
| -5.9437% | |
| -56.148% | |
| 141.6346% | |
| 0% | |
| 34.8023% | |
| 17.1602% | |
| -4.0787% | |
| 17.3504% | |
| 16.3022% | |
| 26.7003% | |
| -46.7114% | |
| 115.6295% | |
| 58.1236% | |
| 18.75% | |
| 0% |